×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Metastatic Breast Cancer

Adam M. Brufsky, MD, PhD, and Lynn Acierno, BSN, RN, OCN, RN-BC, consider the use of CDK4/6 inhibitors in metastatic breast cancer.
Adam M. Brufsky, MD, PhD, and Lynn Acierno, BSN, RN, OCN, RN-BC, discuss stabilized disease in metastatic breast cancer and reinforce the value in routine scans, tumor marker tests, and regular follow up with clinicians.
Martha Carlson
Treatment for metastatic cancer can mean asking a tough question every single day.
Martha Carlson
A patient with metastatic breast cancer discusses what helps her find comfort.
Lauren M. Green
The two oral medicines will be packaged together, only requiring one prescription and one copay, for HR-positive, HER2-negative advanced breast cancer in postmenopausal women.
Being cured and being healed are two different things, and one can happen without the other.
Lauren M. Green
People across the nation are participating in the Metastatic Breast Cancer (MBC) Project to help researchers steer the approach in fighting the disease.  
Anita T. Shaffer
Recent findings may make way for a less expensive treatment option for patients with metastatic breast cancer. 
Silas Inman
Postmenopausal women with locally-advanced or metastatic HR-positive breast cancer benefited from the use of Faslodex (fulvestrant) as a frontline treatment. 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable